U.S., May 1 -- ClinicalTrials.gov registry received information related to the study (NCT06951698) titled 'A Study to Evaluate the Efficacy and Safety of KarXT for the Treatment of Manic Episodes in Bipolar-I Disorder' on April 23.
Brief Summary: The purpose of this study is to evaluate the efficacy and safety of KarXT for the treatment of manic episodes in Bipolar-I Disorder
Study Start Date: June 17
Study Type: INTERVENTIONAL
Condition:
Bipolar-I Disorder With Mania or Mania With Mixed Features
Intervention:
DRUG: KarXT
Specified dose on specified days
OTHER: Placebo
Specified dose on specified days
Recruitment Status: NOT_YET_RECRUITING
Sponsor: Bristol-Myers Squibb
Disclaimer: Curated by HT Syndication....